- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASCO President Julie Vose, MD, to Give Keynote at AJMC's Patient-Centered Oncology Care Meeting
The fourth annual meeting of Patient-Centered Oncology Care, set for November 19-20, 2015, in Baltimore, Maryland, will feature a premiere multi-stakeholder lineup where leading payers, providers, and leaders from pharma will discuss how to deliver value-based care as cost of breakthrough therapies continues to climb. Julie Vose, MD, MBA, FASCO, the president of the American Society of Clinical Oncology, will give the keynote address.
FOR IMMEDIATE RELEASESEPTEMBER 24, 2015
PLAINSBORO, N.J.—Once again, The American Journal of Managed Care will welcome the president of the American Society of Clinical Oncology (ASCO) as the keynote speaker for its annual meeting of stakeholders involved in seeking better value-based solutions for cancer care. Julie Vose, MD, MBA, FASCO, will address the attendees of Patient-Centered Oncology Care on November 19, 2015, the first day of the two-day conference.
Patient-Centered Oncology Care, now in its fourth year, highlights current issues that cut across the research, insurance, regulatory, policy, pharmacy, and technology realms. The event aims to bring together stakeholders from across the healthcare spectrum—who might otherwise not gather in one place—to find solutions for some of the biggest challenges facing cancer care delivery.
Dr. Vose, an internationally recognized expert in the treatment of lymphoma, is the Neumann M. and Mildred E. Harris Professorial Chair and chief of the oncology/hematology division in the Department of Internal Medicine at the University of Nebraska Medical Center. “This meeting is a unique opportunity for those involved in cancer care to discuss possible solutions to today’s challenges in providing high-quality, high-value treatment,” said Dr. Vose.
Earlier this year, Dr. Vose joined more than 100 oncologists to sign a commentary in the Mayo Clinic Proceedings that supported a patient-driven initiative to lower the cost of cancer drugs. As researchers identify more and more breakthrough treatments for cancer, the rising cost of these therapies has generated debate over how much patients, families, and the healthcare system should pay to save or extend lives.
“A lot of times the physicians actually don’t know what the drugs cost,” Dr. Vose said in an interview with AJMC.
While the price of cancer therapy has received attention in recent months, said Brian Haug, president of AJMC, it is not a new topic at this meeting. “These discussions have been at the heart of Patient-Centered Oncology Care since its inception four year ago,” he said.
For the full agenda and registration information, please visit our conference page, http://www.ajmc.com/meetings/pcoc15.
About the Journals and AJMC.com
The American Journal of Managed Care celebrates its 20th year in 2015 as the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Pharmacy Benefits, which provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care, and The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policy makers, and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
Contact:
Nicole Beagin
(609) 716-7777 x 131
About ASCO
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net. For more information about cancer-related policy development, please visit ascoaction.asco.org.
ASCO Contact: Mary Rappaport
571-483-1374
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
March 26th 2025With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
Read More
